Psoriasis

Overview – Psoriasis

Psoriasis is a chronic, immune-mediated skin condition characterised by well-demarcated, erythematous plaques with silvery scale. It is driven by T-cell–mediated inflammation and keratinocyte hyperproliferation, resulting in increased epidermal turnover and thickened plaques. Beyond the skin, psoriasis can present as a multi-system disorder with joint, nail, and gastrointestinal involvement. While not curable, effective treatments can provide substantial relief.


Aetiology

  • Multifactorial: Genetic predisposition and immune dysregulation
  • Environmental and lifestyle triggers:
    • Emotional stress
    • Skin trauma (Koebner phenomenon)
    • Infections and some medications

Pathogenesis

  • T-cell driven immune activation:
    • Sensitised T lymphocytes infiltrate the skin
    • Release of cytokines and growth factors → epidermal hyperplasia
    • Stimulates:
      • Keratinocyte proliferation (↑ turnover rate)
      • Vascular proliferation
      • Chronic inflammation

Morphology

Gross Appearance

  • Classic plaques with:
    • Silvery-white scales
    • Well-demarcated margins
    • Erythematous base
    • Bilateral and symmetrical distribution
  • Nail changes:
    • Pitting
    • Onycholysis (nail separation)
    • Nail dystrophy
  • Auspitz sign: pinpoint bleeding when scale is removed

Histology

  • Acanthosis (epidermal thickening with elongated rete ridges)
  • Parakeratosis (retention of nuclei in stratum corneum)
  • Neutrophilic microabscesses in the epidermis (Munro’s abscesses)
  • Tortuous vessels in the papillary dermis

Clinical Features

  • Can present at any age, including infancy
  • Typically lifelong with relapsing-remitting course
  • Lesions are:
    • Not itchy (though pruritus may occur in some cases)
    • Symmetrically distributed
    • Common on:
      • Elbows, knees, scalp, sacrum, nails
  • Systemic manifestations:

Diagnosis

  • Primarily clinical based on typical morphology and distribution
  • Punch biopsy can confirm diagnosis if uncertain

Management

Topical

  • Emollients
  • Coal tar preparations
  • Dithranol
  • Salicylic acid
  • Vitamin D analogues (e.g. calcipotriol)
  • Topical corticosteroids

Phototherapy

  • Sunlight may improve symptoms
  • UVB phototherapy for widespread or refractory disease

Systemic (For Moderate to Severe Disease)

  • Methotrexate
  • Ciclosporin
  • Acitretin
  • Biologics may be used in severe or treatment-resistant cases

Prognosis

  • Chronic, with no definitive cure
  • Symptoms fluctuate in severity
  • Management focuses on remission and symptom control
  • Stress is a recognised exacerbating factor

Summary – Psoriasis

Psoriasis is a lifelong, immune-mediated condition presenting with well-demarcated, scaly plaques and often accompanied by systemic features such as nail changes and arthritis. It is diagnosed clinically and managed with topical therapy, phototherapy, and systemic agents depending on severity. For a broader context, see our Skin & Dermatology Overview page.

Shopping Cart
Scroll to Top